Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Benign Vascular Lesions”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Post-approval studies (Phase 4)WithdrawnNCT01250457
What this trial is testing

Topical Timolol for the Treatment of Benign Vascular Periocular Lesions

Who this might be right for
Benign Vascular Periocular Lesions
Loyola University
Not applicableStudy completedNCT01745627
What this trial is testing

755nm Alex Laser for Treatment of Pigmented and Vascular Lesions and Scars

Who this might be right for
Benign Pigmented and Vascular Lesions and Scars
Cynosure, Inc. 43
Not applicableStudy completedNCT04807205
What this trial is testing

Post Market Study Using The Elite IQ Device

Who this might be right for
Hair RemovalPseudo Folliculitis BarbaeBenign Vascular Lesion+1 more
Cynosure, Inc. 20
Not applicableActive Not RecruitingNCT06202274
What this trial is testing

Clinical Study to Evaluate the Safety and Efficacy of Candela Technology

Who this might be right for
Hair ReductionTattoo RemovalWrinkle+4 more
Candela Corporation 500
Not applicableStudy completedNCT05096247
What this trial is testing

Post Market Study To Collect Efficacy Data For The Treatment Of Wrinkles With A Radiofrequency Device

Who this might be right for
WrinkleBenign Pigmented LesionsBenign Vascular Lesions
Cynosure, Inc. 48
Testing effectiveness (Phase 2)Study completedNCT06322342
What this trial is testing

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Who this might be right for
Central Nervous System (CNS) LesionsBrain MetastasesBrain Neoplasms+22 more
Reveal Pharmaceuticals Inc. 18